8-K ·Filed Jul 8, 2026
8-K context-dependent: Items 5.02, 7.01
Actionable Insight • Neutral
Routine board appointment with no immediate trading implications. Monitor for any future strategic shifts, but this filing alone does not warrant action.
Final — all horizons settled through T+60d
MRNA ▲ +160.94% at T+60d
NEUTRAL call ✓ call won +160.94% · α vs SPY +158.62% · entry $73.80 → $192.57
T+1d
+3.74%
call +3.74% · α +2.89%
$76.56
settled 3mo ago
T+5d
-8.62%
call -8.62% · α -9.48%
$67.44
settled 3mo ago
T+20d
-23.77%
call -23.77% · α -27.05%
$56.26
settled 8w ago
T+60d
+160.94%
call +160.94% · α +158.62%
$192.57
settled yesterday
Price Chart
Loading chart...
Executive Summary
Moderna appointed Michael McDonnell, former CFO of Biogen, to its Board of Directors effective July 8, 2026. McDonnell will also serve on the Audit Committee. This is a routine board governance change with no material financial or operational impact.
Key Facts
- Michael McDonnell appointed to Board of Directors effective July 8, 2026
- McDonnell formerly served as CFO of Biogen Inc. (Aug 2020 – Feb 2025) and previously at IQVIA, Intelsat, MCG Capital, and EchoStar
- McDonnell will serve as Class II director until the 2029 annual meeting and on the Audit Committee
- David Rubenstein moved off the Audit Committee to the Nominating and Corporate Governance Committee
Financial Impact
No financial impact from this board appointment
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
13% bullish (30 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001682852-26-000134 |
| Exhibit: exhibit991-07082026.htm | 0001682852-26-000134 |
| Document: 0001682852-26-000134-index-headers.html | 0001682852-26-000134 |
| Document: 0001682852-26-000134-index.html | 0001682852-26-000134 |
| Document: 0001682852-26-000134.txt | 0001682852-26-000134 |
18 reports for MRNA
80% Hit rate best @ T+60▲ +14.15%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 30, 2026 2d ago | ANALYST-DOWNGRADE | — | awaiting T+20 | — | — |
Sep 3, 2026 29d ago | ANALYST-DOWNGRADE | $148.87 $190.01 | ▼ −27.63% | ▼ −28.82% | $190.01 (−27.63%) |
Aug 31, 2026 4w ago | Court Ruling | $140.19 $203.46 | ▼ −45.13% | ▼ −45.50% | $190.01 (−35.54%) |
Aug 25, 2026 5w ago | ANALYST-UPGRADE | $158.83 $182.11 | ▲ +14.66% | ▲ +13.68% | $190.01 (+19.63%) |
Aug 19, 2026 6w ago | ANALYST-UPGRADE | $174.38 $158.07 | ▼ −9.35% | ▼ −7.40% | $190.01 (+8.96%) |
Aug 5, 2026 8w ago | 144 | $56.26 $150.81 | ▼ −168.08% | ▼ −168.68% | $190.01 (−237.77%) |
Jul 31, 2026 9w ago | 8-K | $54.82 $137.99 | ▲ +151.71% | ▲ +148.73% | $190.01 (+246.61%) |
Jul 10, 2026 12w ago | 3 | $67.01 $59.81 | ▼ −10.74% | ▼ −13.93% | $190.01 (+183.55%) |
Jul 8, 2026 12w ago | 8-K | $73.80 $56.26 | ▼ −23.77% | ▼ −27.05% | $190.01 (+157.47%) |
Jun 18, 2026 15w ago | 144 | $63.96 $63.15 | ▼ −1.27% | ▼ −1.80% | $190.01 (+197.08%) |
Showing 10 of 18
US Market Status
Market Closed — Opens Mon (64h 10m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access